Dictionary

allow_url_fopen is ENABLED Dictionary Search

dyne

Synonyms

Noun

1. force unit

Usage
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026? - The Motley Fool
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026? - Yahoo Finance
Will Barry Greene’s Board Role Shape Dyne Therapeutics’ (DYN) Path From Platform to Products? - simplywall.st
Price to book forward of Dyne Therapeutics, Inc. – NASDAQ:DYN - TradingView
Dyne Submits BLA for Z-Rostudirsen in Exon 51 Skipping Duchenne Muscular Dystrophy - NeurologyLive
Sallye Van Dyne Obituary (1947 - 2026) - Independence, KY - LINK nky - Legacy obituary
MDA 2026: Dyne therapy boosts strength, cognition in DM1 - Muscular Dystrophy News
Atlas funds linked to Dyne (DYN) director sell 504,695 shares - Stock Titan
Dyne commences Phase III HARMONIA trial for DM1 therapy - Clinical Trials Arena
Sam Van Dyne - On3
Dyne Therapeutics Expands Debt Facility of Up to $400MM with Hercules Capital - ABF Journal
Dyne Therapeutics(DYN.US) Director Sells US$10.71 Million in Common Stock - Moomoo
REGENXBIO, Novartis, Dyne near FDA submissions in muscular dystrophies - BioSpace
MDA 2026: Dyne advances DMD therapy z-rostudirsen toward approval - Muscular Dystrophy News
Enterprise value to EBIT forward of Shandong Wit Dyne Health Co., Ltd. Class A – SZSE:000915 - TradingView
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Dyne hopes to bring new treatment for DM1 to US market in 2028 - Muscular Dystrophy News
Dyne therapeutics director Jason Rhodes sells $10.7m in stock - Investing.com
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. - GlobeNewswire
Advancing DM1 and DMD Care: Insights on DYNE-101 and DYNE-251 Development - NeurologyLive
Dyne Therapeutics Appoints Barry Greene to Board of Directors - Yahoo Finance
Global trial testing Dyne’s Z-rostudirsen for boys with DMD now underway - Muscular Dystrophy News
Dyne, citing positive trial data, to ask FDA to approve DMD therapy - Muscular Dystrophy News
[144] Dyne Therapeutics, Inc. SEC Filing - Stock Titan
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone - Yahoo Finance
Dyne Therapeutics (DYN) Concludes Phase 1/2 ACHIEVE Trial Enrollment - Yahoo Finance
Dyne to seek accelerated approval of DMD drug on Phase I/II data - Clinical Trials Arena
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1) - GlobeNewswire
Dyne Plans Post-Prasad FDA Run as Duchenne Exon Skipper Sustains Benefit in Long Term Data - BioSpace
Susanne Van Dyne Obituary August 24, 2010 - Munden Funeral Home
WilmerHale Advises Dyne Therapeutics on its $402.5 Million Public Offering of Common Stock - WilmerHale
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy - Yahoo Finance
Dyne Therapeutics (DYN) Adds Barry Greene And Expands Funding, Is The Stock Still A Bargain? - simplywall.st
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition - BioSpace
Yamuna Meleth, Rose Van Dyne and Corrie Farbsten Photo (August 15, 2021) - BroadwayWorld
Dyne Therapeutics Announces Submission of Biologics License - GlobeNewswire
Could Dyne Therapeutics’ (DYN) AMCP Spotlight Reveal How New FDA Leadership May Shape Its Pipeline? - Yahoo Finance
Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD - NeurologyLive
Dyne Therapeutics Announces Upcoming Presentation - GlobeNewswire
Patty Lou (Crum) Van Dyne Obituary Apr 26, 2026 - wilsonfuneralhomes.com
Form 4 Dyne Therapeutics Inc For: 30 June By Investing.com - Investing.com South Africa
Biotech Dyne adds $400M debt to advance two rare disease drugs - Stock Titan
Diane Fitzgerald Dyne - www.warwickadvertiser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics - The National Law Review
Dyne readies FDA push after DMD exon 51 med excels in trial - Fierce Biotech
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Dyne Therapeutics adds ex-Sage CEO Barry Greene to board - Stock Titan
Dyne Therapeutics Insider Sold Shares Worth $5,646,497, According to a Recent SEC Filing - Moomoo
Dyne therapeutics director Jason Rhodes sells $10.7m in stock By Investing.com - Investing.com South Africa
TD Cowen Initiates Dyne Therapeutics at Buy - Moomoo
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Dyne Therapeutics (DYN) Is Up 12.1% After Expanding Debt Facility And Adding Veteran Biotech Director - simplywall.st
Dyne Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Dyne awards stock options, RSUs to 6 newly hired employees - Stock Titan
Dyne Therapeutics (DYN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs - Yahoo Finance
Dyne Therapeutics’ Exon Skipping Duchenne Therapy Delivers Good Results - Inside Precision Medicine
Dyne Therapeutics (DYN) director-linked funds sell 267,760 shares - Stock Titan
Dyne Therapeutics plans to file for approval for next-generation Duchenne drug - STAT
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares - The Motley Fool
Dyne Therapeutics: 'Strong Buy' Due To Upcoming Z-Rostudirsen BLA Submission (DYN) - Seeking Alpha
Dyne Therapeutics stock initiated at buy by TD Cowen on platform - Investing.com
Dyne Therapeutics (NASDAQ: DYN) CFO sells 2,362 shares to cover taxes - Stock Titan
Dyne Therapeutics Expands Hercules Capital Debt Facility to Up to $400 Million - citybiz
Dyne Therapeutics (DYN) Adds Barry Greene And Expands Funding, Is The Stock Still A Bargain? - Sahm
Dyne Therapeutics: Why The $350M Public Offering Was Critical (NASDAQ:DYN) - Seeking Alpha
A Look At Dyne Therapeutics (DYN) Valuation As Phase 3 FORZETTO Trial Marks Key Development Milestone - Yahoo Finance
Dyne Therapeutics(DYN.US) Director Sells US$5.65 Million in Common Stock - Moomoo
Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance
Dyne therapeutics director Jason P Rhodes sells $5.65m in stock - Investing.com
Dyne Therapeutics appoints Barry Greene to board of directors - Investing.com
A Look At Dyne Therapeutics (DYN) Valuation After Q4 2025 Earnings Beat And Ongoing Clinical Progress - Yahoo Finance
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean - The Motley Fool
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Dyne Therapeutics (NASDAQ: DYN) director Barry Greene files initial Form 3 - Stock Titan
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. - Sahm
Dyne Therapeutics elects Barry E. Greene to Board as Class I director - TradingView
Dyne Therapeutics (DYN) director-affiliated fund sells 263,962 shares under 10b5-1 plan - Stock Titan
PetAg® Launches Dyne™ Soft Chews Nationwide, Bringing Science‑Backed Daily Wellness to Dogs Everywhere - PR Newswire
Experimental Duchenne treatment from Dyne heads to FDA - Stock Titan
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy Ahead of Planned BLA Submission for U.S. Accelerated Approval - Investing News Network
Dyne Therapeutics Insider Sold Shares Worth $5,464,611, According to a Recent SEC Filing - Moomoo
A Look At Dyne Therapeutics (DYN) Valuation After Key ACHIEVE Trial Enrollment Milestone - Yahoo Finance
Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade - Yahoo Finance
Dyne’s Exon Skipper Delivers ‘Best Ever’ Functional Outcomes in Early DMD Study - BioSpace
Dyne Robert Hoenie Obituary (2026) - Celina, OH - W.H. Dick & Sons Hellwarth Funeral Homes - Legacy obituary
Enterprise value to EBIT forward of Dyne Therapeutics, Inc. – NASDAQ:DYN - TradingView
Enterprise value to EBITDA forward of Dyne Therapeutics, Inc. – NASDAQ:DYN - TradingView
Dyne Therapeutics Initiates Phase 3 FORZETTO Trial of Zeleciment Rostudirsen for Duchenne Muscular Dystrophy - Quiver Quantitative
Barry Greene joins Dyne Therapeutics (DYN) board with new option grant - Stock Titan
Dyne Therapeutics(DYN.US) Director Sells US$5.46 Million in Common Stock - Moomoo
Dyne Therapeutics (DYN) CCO auto-sells shares to cover RSU tax withholding - Stock Titan
Price to earnings forward of Dyne Therapeutics Inc – BX:DYN - TradingView
Director at Dyne Therapeutics (DYN) awarded 57,463 stock options vesting over 3 years - Stock Titan
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval - Yahoo Finance
Enterprise value to revenue forward of Dyne Therapeutics, Inc. – NASDAQ:DYN - TradingView
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1) - Yahoo Finance
DYN - Dyne Therapeutics Inc Stock Price and Quote - Finviz
Dyne Therapeutics (DYN) CMO auto-sells shares to cover tax withholding - Stock Titan
Foreign Language Equivalents
Foreign Language Equivalents of 'dyne'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ddyne,   dynne,   dybe,   ydne,   dyn,   yne,   dyen,   dune,   dne,   dye,   syne,   dnye,   dynw,   dynr,   fyne,   dtne,   dyyne,   dyme,   dynee
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z